153 related articles for article (PubMed ID: 29286651)
1. Predictive Power of Different Types of Experimental Restraints in Small Molecule Docking: A Review.
Fu DY; Meiler J
J Chem Inf Model; 2018 Feb; 58(2):225-233. PubMed ID: 29286651
[TBL] [Abstract][Full Text] [Related]
2. NMR in structure-based drug design.
Carneiro MG; Ab E; Theisgen S; Siegal G
Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
[TBL] [Abstract][Full Text] [Related]
3. In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.
Hoffer L; Renaud JP; Horvath D
J Chem Inf Model; 2013 Apr; 53(4):836-51. PubMed ID: 23537132
[TBL] [Abstract][Full Text] [Related]
4. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
5. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design.
Morency LP; Gaudreault F; Najmanovich R
Methods Mol Biol; 2018; 1762():367-388. PubMed ID: 29594781
[TBL] [Abstract][Full Text] [Related]
6. Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach.
Lam PC; Abagyan R; Totrov M
J Comput Aided Mol Des; 2018 Jan; 32(1):187-198. PubMed ID: 28887659
[TBL] [Abstract][Full Text] [Related]
7. DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations.
Cuzzolin A; Sturlese M; Malvacio I; Ciancetta A; Moro S
Molecules; 2015 May; 20(6):9977-93. PubMed ID: 26035098
[TBL] [Abstract][Full Text] [Related]
8. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
Daga PR; Polgar WE; Zaveri NT
J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
[TBL] [Abstract][Full Text] [Related]
9. Improving docking results via reranking of ensembles of ligand poses in multiple X-ray protein conformations with MM-GBSA.
Greenidge PA; Kramer C; Mozziconacci JC; Sherman W
J Chem Inf Model; 2014 Oct; 54(10):2697-717. PubMed ID: 25266271
[TBL] [Abstract][Full Text] [Related]
10. Merging Ligand-Based and Structure-Based Methods in Drug Discovery: An Overview of Combined Virtual Screening Approaches.
Vázquez J; López M; Gibert E; Herrero E; Luque FJ
Molecules; 2020 Oct; 25(20):. PubMed ID: 33076254
[TBL] [Abstract][Full Text] [Related]
11. Molecular Docking Simulations with ArgusLab.
Bitencourt-Ferreira G; de Azevedo WF
Methods Mol Biol; 2019; 2053():203-220. PubMed ID: 31452107
[TBL] [Abstract][Full Text] [Related]
12. Force Field Optimization Guided by Small Molecule Crystal Lattice Data Enables Consistent Sub-Angstrom Protein-Ligand Docking.
Park H; Zhou G; Baek M; Baker D; DiMaio F
J Chem Theory Comput; 2021 Mar; 17(3):2000-2010. PubMed ID: 33577321
[TBL] [Abstract][Full Text] [Related]
13. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
[TBL] [Abstract][Full Text] [Related]
14. Novel insights of structure-based modeling for RNA-targeted drug discovery.
Chen L; Calin GA; Zhang S
J Chem Inf Model; 2012 Oct; 52(10):2741-53. PubMed ID: 22947071
[TBL] [Abstract][Full Text] [Related]
15. Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective.
Saikia S; Bordoloi M
Curr Drug Targets; 2019; 20(5):501-521. PubMed ID: 30360733
[TBL] [Abstract][Full Text] [Related]
16. Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.
Singh N; Chaput L; Villoutreix BO
J Chem Inf Model; 2020 Aug; 60(8):3910-3934. PubMed ID: 32786511
[TBL] [Abstract][Full Text] [Related]
17. Combined strategies in structure-based virtual screening.
Wang Z; Sun H; Shen C; Hu X; Gao J; Li D; Cao D; Hou T
Phys Chem Chem Phys; 2020 Feb; 22(6):3149-3159. PubMed ID: 31995074
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule ligand docking into comparative models with Rosetta.
Combs SA; Deluca SL; Deluca SH; Lemmon GH; Nannemann DP; Nguyen ED; Willis JR; Sheehan JH; Meiler J
Nat Protoc; 2013; 8(7):1277-98. PubMed ID: 23744289
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics in drug design.
Zhao H; Caflisch A
Eur J Med Chem; 2015 Feb; 91():4-14. PubMed ID: 25108504
[TBL] [Abstract][Full Text] [Related]
20. Experimental free ligand conformations: a missing link in structure-based drug discovery.
Chiarparin E; Packer MJ; Wilson DM
Future Med Chem; 2019 Jan; 11(2):79-82. PubMed ID: 30648432
[No Abstract] [Full Text] [Related]
[Next] [New Search]
